Results 141 to 150 of about 210,319 (212)

Cost-effectiveness of novel antiandrogens for the treatment of nmCRPC patients in the Chinese healthcare system. [PDF]

Ther Adv Urol
Yang W, Zheng B, Zhou M, Li Y, Zheng L, Zhu J, Zhang M.   +6 more
europepmc   +1 more source

First-line enfortumab vedotin-pembrolizumab versus nivolumab plus gemcitabine-cisplatin in metastatic urothelial cancer: a cost-effectiveness study. [PDF]

Front Public Health
Ying H, Fu B.
europepmc   +1 more source

Clinical impact and cost-effectiveness of vaccinating infants and adolescents against invasive meningococcal B disease in the Netherlands. [PDF]

BMC Med
Otten T, Knol M, Montessori LM, de Boer P, Steens A.   +4 more
europepmc   +1 more source

Nivolumab plus ipilimumab versus lenvatinib or sorafenib for US and Chinese patients with unresectable hepatocellular carcinoma: a cost-effectiveness analysis. [PDF]

Front Public Health
Wu Q, Qin Y, Li Q.
europepmc   +1 more source

Cost-effectiveness of routine influenza vaccination program for individuals aged 65 years and older in Japan: Substituting standard-dose inactivated vaccine with high-dose inactivated vaccine. [PDF]

IJID Reg
Hoshi SL, Seposo X, Kondo M.
europepmc   +1 more source

The Efficiency and Cost-Effectiveness of 3D-Printed Patient-Specific Guide Plate for Patients Undergoing Open-Wedge High Tibial Osteotomy: A Multicentered Randomized Controlled Trial. [PDF]

Orthop Surg
Zhou R, Guo Y, Wang R, Xu M, Kang Q, Shen Y, Xu J, Zhong D, Lu S.   +8 more
europepmc   +1 more source

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma: A cost-effectiveness analysis. [PDF]

Cancer
Luo J, Li Z, Ge J, Cai S, Mo X, Liu W, Gui C, Du Q, Liu J.   +8 more
europepmc   +1 more source

A Cost-Effectiveness Analysis of the Sentio Bone Conduction Hearing Implant System in the Australian Healthcare Setting. [PDF]

J Mark Access Health Policy
Värendh M, Haggren I, Lagerkvist H, Åberg Håkansson M, Hjelmgren J.   +4 more
europepmc   +1 more source

Deep brain stimulation for Parkinson's disease in Thailand: cost, utility and policy implications for universal health coverage. [PDF]

BMJ Neurol Open
Aungsumart S, Songpattanasilp A, Rujirussawarawong S, Ounmuang C, Sathirapanya P, Limotai N.   +5 more
europepmc   +1 more source